Showing 781 - 800 results of 12,887 for search '(( 10 ((nm decrease) OR (nn decrease)) ) OR ( 50 ((ns decrease) OR (mean decrease)) ))', query time: 0.55s Refine Results
  1. 781

    Shape-Based Reprofiling of FDA-Approved Drugs for the H<sub>1</sub> Histamine Receptor by Sridhar R. Vasudevan (589877)

    Published 2012
    “…Reprofiling of existing drugs to treat conditions not originally targeted is an attractive means of addressing the problem of a decreasing stream of approved drugs. …”
  2. 782
  3. 783
  4. 784

    Dynamic Regulation of Proton and Water Transport through an Acylhydrazone-Based Photoresponsive Channel by Paras Wanjari (22259362)

    Published 2025
    “…Upon irradiation at 310 nm, all derivatives showed increased proton transport rates, which subsequently decreased after exposure to 365 nm, confirming the photoresponsive behavior of the system. …”
  5. 785

    The effect of glibenclamide on channel activity at +20, 0 and -20 mV. by Sajjad Salari (736104)

    Published 2015
    “…Histogram bars show current amplitudes and P<sub>o</sub> of reconstituted channels in absence or presence of glibenclamide. The addition of 50 μM glibenclamide resulted in a decreased current jump amplitude and a reduction in P<sub>o</sub>. 100 μM glibenclamide caused a total channel inhibition at +20 and 0 mV (n = 5), but was ineffective at -20 mV. …”
  6. 786

    Tendency chart of monthly FVC mean. by Yichuan Zhang (2888345)

    Published 2024
    “…The dynamic changes of monthly FVC at regional scale were described through the dynamic changes in the monthly FVC mean and in the FVC areas at various scales, and the dynamic changes in the monthly FVC were analyzed using the coefficient of variation and curve change trends. …”
  7. 787
  8. 788

    670 nm light treatment reduces mean clinical score and signs of MOG-induced EAE. by Kamaldeen A. Muili (297505)

    Published 2013
    “…(<b>D</b>) Mice were treated with 670 nm light (-□-; n = 10) or no light (restraint stress; -▪-; n = 7) using the double-treatment protocol. …”
  9. 789
  10. 790
  11. 791
  12. 792
  13. 793
  14. 794

    Calcineurin acts as a Ca<sup>2+</sup> sensor for metamodulation of LP I<sub>h</sub> in 5nM DA. by Wulf-Dieter C. Krenz (693267)

    Published 2015
    “…Black asterisks indicate that a one-way ANOVA on the four DA-treatment groups with Tukey’s post hoc tests that made all pair wise comparisons showed that the decrease observed for the TTX + DA + (+50 OSC) treatment group was significantly different from the other three DA treatment groups, and that those three DA treatment groups [(TTX+DA, TTX+DA+FK506, TTX+DA+FK506+(+50 OSC)] were not significantly different from one another: (F (3,26) = 11.08; p = 0.0001). …”
  15. 795
  16. 796
  17. 797
  18. 798
  19. 799
  20. 800